Relation of the ischaemic substrate to left ventricular remodelling by cardiac magnetic resonance at 1.5 T in rabbits

European Radiology

Volumn 20, Issue 5, 2010, Pages 1214-1220

  Mansencal, Nicolas ^a   Tissier, Renaud ^a   Deux, Jean François ^b   Ghaleh, Bijan ^a   Couvreur, Nicolas ^a   Rienzo, Mario ^a   Guéret, Pascal ^b   Rahmouni, Alain ^b   Berdeaux, Alain ^a   Garot, Jérôme ^a,b,c  

^a INSERM   (France)

^b HENRI MONDOR HOSPITAL   (France)

^c INSTITUT HOSPITALIER JACQUES CARTIER   (France)

Author keywords

Cardiac; Experimental study; Left ventricular remodelling; Magnetic resonance imaging; Myocardial infarction

Indexed keywords

GADOTERATE MEGLUMINE;

ACCURACY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CINERADIOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DISEASE MODEL; FOLLOW UP; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART LEFT VENTRICLE MASS; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; HEART VENTRICLE REMODELING; HISTOPATHOLOGY; MALE; MEDICAL ASSESSMENT; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RABBIT; TREATMENT PLANNING;

ANIMALS; CHI-SQUARE DISTRIBUTION; CONTRAST MEDIA; DISEASE MODELS, ANIMAL; HETEROCYCLIC COMPOUNDS; LINEAR MODELS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE IMAGING, CINE; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; ORGANOMETALLIC COMPOUNDS; RABBITS; VENTRICULAR REMODELING;

EID: 77952089689     PISSN: 09387994     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00330-009-1660-7     Document Type: Article

References (23)

1. KC Allman LJ Shaw R Hachamovitch, et al. 2002 Myocardial viability testing and impact of revascularisation on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis J Am Coll Cardiol 39 1151 1158 10.1016/S0735-1097(02)01726-6 11923039 (Pubitemid 34267418)
2. JJ Bax D Poldermans A Elhendy, et al. 1999 Improvement o left ventricular ejection fraction, heart failure symptoms and prognosis after revascularization in patients with chronic coronary artery disease and viable myocardium detected by dobutamine stress echocardiography J Am Coll Cardiol 34 163 169 10.1016/S0735-1097(99)00157-6 1:STN:280:DyaK1MzisFGqsQ%3D%3D 10400006
3. RJ Kim E Wu A Rafael, et al. 2000 The use of contrast-enhanced MRI to identify reversible myocardial dysfunction N Engl J Med 343 1445 1453 10.1056/NEJM200011163432003 1:STN:280:DC%2BD3M%2FisFWnsw%3D%3D 11078769
4. R Nijveldt MBM Hofman A Hirsch, et al. 2009 Assessment of microvascular obstruction and prediction of short-term remodeling after acute myocardial infarction: cardiac MR imaging study Radiology 250 363 370 10.1148/radiol. 2502080739 19164698
5. BL Gerber J Garot DA Bluemke, et al. 2002 Accuracy of contrast-enhanced magnetic resonance imaging in predicting improvement of regional myocardial function in patients after acute myocardial infarction Circulation 106 1083 1089 10.1161/01.CIR.0000027818.15792.1E 12196333 (Pubitemid 34970848)
6. HP Kuhl AM Beek AP van der Weerdt, et al. 2003 Myocardial viability in chronic ischemic heart disease: comparison of contrast-enhanced magnetic resonance imaging with (18)F-fluorodeoxyglucose positron emission tomography J Am Coll Cardiol 41 1341 1348 10.1016/S0735-1097(03)00158-X 12706930 (Pubitemid 36442708)
7. A Wagner H Mahrholdt TA Holly, et al. 2003 Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study Lancet 361 374 379 10.1016/S0140-6736(03)12389-6 12573373 (Pubitemid 36164969)
8. AA Cochet L Lorgis A Lalande M Zeller JC Beer PM Walker C Touzery JE Wolf F Brunotte Y Cottin 2009 Major prognostic impact of persistent microvascular obstruction as assessed by contrast-enhanced cardiac magnetic resonance in reperfused acute myocardial infarction Eur Radiol 19 2117 2126 10.1007/s00330-009-1395-5 19350245
9. P Hunold T Schlosser J Barkhausen 2006 Magnetic resonance cardiac perfusion imaging-a clinical perspective Eur Radiol 16 1779 1188 10.1007/s00330-006-0269-3 16670865 (Pubitemid 44027381)
10. RJ Kim EL Chen JA Lima, et al. 1996 Myocardial Gd-DTPA kinetics determine MRI contrast enhancement and reflect the extent and severity of myocardial injury after acute reperfused infarction Circulation 94 3318 3326 1:STN:280:DyaK2s7ktlWgtw%3D%3D 8989146
11. RJ Kim DS Fieno TB Parrish, et al. 1999 Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function Circulation 100 1992 2002 1:STN:280:DC%2BD3c%2FivVensg%3D%3D 10556226
12. DS Fieno RJ Kim EL Chen, et al. 2000 Contrast-enhanced magnetic resonance imaging of myocardium at risk: distinction between reversible and irreversible injury throughout infarct healing J Am Coll Cardio l36 1985 1991 10.1016/S0735-1097(00)00958-X
13. J Barkhausen W Ebert JF Debatin, et al. 2002 Imaging of myocardial infarction: comparison of Magnevist and Gadophrin-3 in rabbits J Am Coll Cardiol 39 1392 1398 10.1016/S0735-1097(02)01777-1 1:CAS:528:DC%2BD38XjsFait70%3D 11955861 (Pubitemid 34297883)
14. DM Yellon GF Baxter 2000 Protecting the ischaemic and reperfused myocardium in acute myocardial infarction: distant dream or near reality? Heart 83 381 387 10.1136/heart.83.4.381 1:STN:280:DC%2BD3c7osl2rtQ%3D%3D 10722532
15. R Tissier K Aouam A Berdeaux B Ghaleh 2003 Evidence for a ceiling of cardioprotection with a nitric oxide donor-induced delayed preconditioning in rabbits J Pharmacol Exp Ther 306 528 531 10.1124/jpet.103.052563 1:CAS:528:DC%2BD3sXlslGltb8%3D 12730360 (Pubitemid 36886150)
16. R Tissier X Waintraub N Couvreur, et al. 2007 Pharmacological postconditioning with the phytoestrogen genistein J Mol Cell Cardiol 42 79 87 10.1016/j.yjmcc.2006.10.007 1:CAS:528:DC%2BD2sXht1CksQ%3D%3D 17141266 (Pubitemid 44958633)
17. M Saeed J Bremerich MF Wendland, et al. 1999 Reperfused myocardial infarction as seen with use of necrosis-specific versus standard extracellular contrast agents in rats Radiology 213 247 257 1:STN:280:DC%2BD3c%2FgvVWrsA%3D%3D 10540668
18. E Carluccio P Biagioli G Alunni, et al. 2006 Patients with hibernating myocardium show altered left ventricular volumes and shape, which revert after revascularization: evidence that dyssynergy might directly induce cardiac remodeling J Am Coll Cardiol 47 969 977 10.1016/j.jacc.2005.09.064 16516079
19. PW Pflugfelder G Wisenberg FS Prato, et al. 1986 Serial imaging of canine myocardial infarction by in vivo nuclear magnetic resonance J Am Coll Cardiol 7 843 849 1:STN:280:DyaL287mvFejug%3D%3D 3958342
20. GR Caputo U Sechtem D Tscholakoff, et al. 1987 Measurements of myocardial infarct size at early and late time intervals using MR imaging: an experimental study in dogs Am J Roentgenol 149 237 242 1:STN:280:DyaL2s3mslWjtA%3D%3D
21. DL Johnston S Homma P Liu, et al. 1988 Serial changes in nuclear magnetic resonance relaxation times after myocardial infarction in the rabbit: relationship to water content, severity of ischemia, and histopathology over a six-month period Magn Reson Med 8 363 379 10.1002/mrm.1910080402 1:STN:280:DyaL1M7lvVOnsw%3D%3D 3231066 (Pubitemid 19003354)
22. T Ryan RD Tarver JL Duerk, et al. 1990 Distinguishing viable from infarcted myocardium after experimental ischemia and reperfusion by using nuclear magnetic resonance imaging J Am Coll Cardiol 15 1355 1364 1:STN:280:DyaK3c3ivFKjtA%3D%3D 2329239
23. A Bouchard RC Reeves G Cranney, et al. 1989 Assessment of myocardial infarct size by means of T2-weighted 1H nuclear magnetic resonance imaging Am Heart J 117 281 289 10.1016/0002-8703(89)90770-9 1:STN:280:DyaL1M7jt1aquw%3D%3D 2916403 (Pubitemid 19059774)